Zhejiang Huahai Pharmaceutical Co (SHSE:600521) E10: ¥0.50 (As of Mar. 2026)


SHSE:600521 Zhejiang Huahai Pharmaceutical Co Ltd SHSE:600521
82 GF Score
Price ¥16.26
GF Value ¥16.38
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Zhejiang Huahai Pharmaceutical Co E10?

Zhejiang Huahai Pharmaceutical Co SHSE:600521 -0.55% 82 E10 is ¥0.50 as of Mar. 2026. GuruFocus rates SHSE:600521 with a GF Score™ of 82/100 and a GF Value™ of ¥16.38 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhejiang Huahai Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.270. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.50 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zhejiang Huahai Pharmaceutical Co's average E10 Growth Rate was -2.00% per year. During the past 3 years, the average E10 Growth Rate was 4.60% per year. During the past 5 years, the average E10 Growth Rate was 7.50% per year. During the past 10 years, the average E10 Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Zhejiang Huahai Pharmaceutical Co was 15.20% per year. The lowest was 4.60% per year. And the median was 11.25% per year.

As of today (2026-07-09), Zhejiang Huahai Pharmaceutical Co's current stock price is ¥16.26. Zhejiang Huahai Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was ¥0.50. Zhejiang Huahai Pharmaceutical Co's Shiller PE Ratio of today is 32.52.

During the past 13 years, the highest Shiller PE Ratio of Zhejiang Huahai Pharmaceutical Co was 135.85. The lowest was 26.09. And the median was 52.16.


Zhejiang Huahai Pharmaceutical Co  (SHSE:600521) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhejiang Huahai Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=16.26/0.50
=32.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Zhejiang Huahai Pharmaceutical Co was 135.85. The lowest was 26.09. And the median was 52.16.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Zhejiang Huahai Pharmaceutical Co E10 Related Terms


Zhejiang Huahai Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Zhejiang Huahai Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Huahai Pharmaceutical Co E10 Chart

Zhejiang Huahai Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.42 0.44 0.50 0.48

Zhejiang Huahai Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.50 0.50 0.48 0.50

SHSE:600521 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Huahai Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Huahai Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Huahai Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Huahai Pharmaceutical Co's Shiller PE Ratio falls into.


SHSE:600521
82GF Score
Zhejiang Huahai Pharmaceutical Co Ltd SHSE:600521
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Huahai Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Huahai Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.27/116.3033*116.3033
=0.270

Current CPI (Mar. 2026) = 116.3033.

Zhejiang Huahai Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.098 101.400 0.112
201609 0.098 102.400 0.111
201612 0.083 102.600 0.094
201703 0.106 103.200 0.119
201706 0.112 103.100 0.126
201709 0.136 104.100 0.152
201712 0.109 104.500 0.121
201803 0.118 105.300 0.130
201806 0.045 104.900 0.050
201809 0.018 106.600 0.020
201812 -0.100 106.500 -0.109
201903 0.100 107.700 0.108
201906 0.140 107.700 0.151
201909 0.130 109.800 0.138
201912 0.040 111.200 0.042
202003 0.150 112.300 0.155
202006 0.250 110.400 0.263
202009 0.180 111.700 0.187
202012 0.060 111.500 0.063
202103 0.170 112.662 0.175
202106 0.170 111.769 0.177
202109 0.060 112.215 0.062
202112 -0.070 113.108 -0.072
202203 0.100 114.335 0.102
202206 0.290 114.558 0.294
202209 0.160 115.339 0.161
202212 0.250 115.116 0.253
202303 0.120 115.116 0.121
202306 0.270 114.558 0.274
202309 0.110 115.339 0.111
202312 0.070 114.781 0.071
202403 0.190 115.227 0.192
202406 0.330 114.781 0.334
202409 0.190 115.785 0.191
202412 0.060 114.893 0.061
202503 0.210 115.116 0.212
202506 0.070 114.907 0.071
202509 -0.020 115.471 -0.020
202512 -0.080 115.832 -0.080
202603 0.270 116.303 0.270

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.50 mean?
Zhejiang Huahai Pharmaceutical Co (SHSE:600521) has a E10 of ¥0.50 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Zhejiang Huahai Pharmaceutical Co and its competitors.
Is Zhejiang Huahai Pharmaceutical Co's E10 too high?
Zhejiang Huahai Pharmaceutical Co's current E10 is ¥0.50. Overall, Zhejiang Huahai Pharmaceutical Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Huahai Pharmaceutical Co's E10 compare to ZTS and UTHR?
Zhejiang Huahai Pharmaceutical Co's E10 of ¥0.50 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Zhejiang Huahai Pharmaceutical Co and its competitors. Zhejiang Huahai Pharmaceutical Co's current E10 is ¥0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Huahai Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Huahai Pharmaceutical Co (SHSE:600521) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.38, compared to a current price of ¥16.26 — trading 0.7% below its estimated fair value. The current E10 is ¥0.50. Zhejiang Huahai Pharmaceutical Co's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Zhejiang Huahai Pharmaceutical Co (SHSE:600521), the current E10 is ¥0.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Huahai Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥16.26 is trading 0.7% below its estimated GF Value™ of ¥16.38. GuruFocus considers Zhejiang Huahai Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600521:

  • E10: ¥0.50
  • GF Value™: ¥16.38 vs. price of ¥16.26 (0.7% below fair value)
  • GF Score™: 82/100 with 8 warning signs

No single metric tells the full story. See the SHSE:600521 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Huahai Pharmaceutical Co Business Description

Address Xunqiao, Zhejiang Province, Linhai, CHN, 317024
Zhejiang Huahai Pharmaceutical Co Ltd is engaged in research and development, production, and sales of multi-dosage preparations, biological drugs, innovative drugs, and specialty APIs. The company's products include irbesartan hydrochlorothiazide tablets, losartan potassium tablets, paroxetine hydrochloride tablets, sertraline hydrochloride tablets, linagliptin tablets, dabigatran etexilate capsules, pemetrexed disodium for injection, esomeprazole magnesium enteric-coated capsules, torsemide injection, and others.
82GF Score

Get the complete analysis for SHSE:600521

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥16.26
Price
¥16.38
GF Value